GSK Institutes Changes to Pay Rules for Sales Force and Doctors
publication date: Dec 18, 2013
GlaxoSmithKline made changes to two of its questionable marketing practices, aiming to be at the forefront of ethical changes in the pharmaceutical industry. The company said (1) it will no longer pay its sales people for meeting sales targets, and (2) it will stop paying doctors for speaking about GSK products or attending conferences. GSK never mentioned the word “China” as it discussed the new system, even though the old payment rules were partly to blame for China’s bribery scandal that erupted this year. More details....
Stock Symbol: (NYSE: GSK)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.